Ki-Hyun Kim

This inventor holds 106 USPTO granted patents and 17 published patent applications and 26 EPO patents, primarily in Rechargeable Lithium Batteries (CPC class H02J7-025). Top assignees: Samsung Electronics Co., Ltd., Samsung Sdi Co., Inc., Seoul National University. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki-Hyun Kim. Retrieved from https://idiyas.com/inventor/ki-hyun-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 106 (Patent Applications = 17)

% Patents Active = 77.4

EPO Patents = 26 (Patent Applications = 36)

Average Co-Inventor Count = 4.2

ph-index = 11

Forward Citations = 498(Granted Patents)

Forward Citations (Not Self Cited) = 451(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Yusong-ku, KR (1999)
Suwon-shi, KR (2001 - 2006)
Uiwang-si, KR (2010)
Suwan-si, KR (2016)
Gyeonggo-do, KR (2016)
Hwaseong-si, KR (2011 - 2018)
Gyeonggi-do, KR (2005 - 2021)
Yongin-si, KR (2013 - 2021)
Anyang-si, KR (2018 - 2021)
Suwon-si, KR (2010 - 2022)
Seoul, KR (2000 - 2023)
Daejeon, KR (2006 - 2023)

Company Filing History:

81 out of 132,108

Samsung Electronics Co., Ltd.

patents

9 out of 7,663

Samsung Sdi Co., Inc.

patents

7 out of 1,779

Seoul National University

patents

4. 2 out of 11,769

Electronics and Telecommunications Research Institute

Leland Stanford Junior University

patents

7. 2 out of 3,374

Lg Energy Solution, Ltd.

Daewoo Electronics Co., Ltd.

patents

10. 1 out of 126

Industry-University Cooperation Foundation Sogang University

patents

11. 1 out of 12

Institut Pasteur Korea

patents

12. 1 out of 9

Korea District Heating Corporation

patents

13. 1 out of 334

Korea Research Institute of Bioscience and Biotechnology

Qualcomm Incorporated

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Rechargeable Lithium Battery

Wireless Charging

Semiconductor Devices

Chimeric Antigen Receptor

Natural Killer Cells

Evaluation Systems

Cordless Charging

Polymer Electrolyte Membrane

Battery Balancing

Electronic Device

Wearable Device

Positive Active Material

106 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12463207 - Lithium metal negative electrode and electrochemical device comprising the same (2025-11-04),

2. 12383791 - Method for evaluating athlete, system and device performing the same (2025-08-12),

3. 11839794 - Method for evaluating athlete, system and device performing the same (2023-12-12),

4. 11707486 - Natural killer cell expressing anti-cotinine chimeric antigen receptor (2023-07-25),

5. 11552378 - Fusing apparatus (2023-01-10),

6. 11478555 - Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof (2022-10-25),

7. 11402146 - Refrigerator (2022-08-02),

8. 11326827 - Refrigerator (2022-05-10),

9. 11149243 - Electronic device, wearable device, and method of providing content-based somatic senses using ultrasound (2021-10-19),

10. 11108271 - Electronic device including multiple coils (2021-08-31),

11. 11088570 - Portable terminal including multiple coil (2021-08-10),

12. 11005271 - Battery balancing apparatus and battery balancing method (2021-05-11),

13. RE48518 - Wireless charging apparatus and portable terminal including the same (2021-04-12),

14. 10947299 - Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for same (2021-03-16),

15. 10930934 - Positive active material for rechargeable lithium battery and rechargeable lithium battery including same (2021-02-23),

Title: Innovations and Achievements of Ki-Hyun Kim

Introduction

Ki-Hyun Kim, based in Gyeonggi-do, South Korea, is a prominent inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 101 patents, he has made substantial strides in developing innovative therapeutic solutions, particularly in cancer treatment.

Latest Patents

Among his latest inventions are groundbreaking patents involving natural killer (NK) cells and chimeric antigen receptors (CARs). One notable patent, titled "Natural Killer Cell Expressing Anti-Cotinine Chimeric Antigen Receptor," discloses an NK cell capable of specifically binding to cotinine. This innovative approach allows the NK cell to effectively target tumor tissues across various types of cancers, providing an efficient gene therapy with anticancer effects.

Another significant patent titled "Chimeric Antigen Receptor to Which Anti-Cotinine Antibody Is Linked" showcases a chimeric antibody receptor that interacts with cotinine. This development involves T cells that secrete interferon gamma to induce the death of cells expressing the targeted molecule. Additionally, the patent suggests administering a cytotoxic agent conjugated with cotinine to manage any hyperactivity of the T cells, ensuring a balanced and safe cancer treatment strategy.

Career Highlights

Ki-Hyun Kim has had a distinguished career in the research and development sector, working for reputable companies such as Samsung Electronics Co., Ltd. and Samsung SDI Co., Inc. His roles in these organizations have allowed him to refine his innovative skills and contribute to various high-impact projects.

Collaborations

Throughout his career, Ki-Hyun Kim has collaborated with fellow researchers and inventors, including Se-Ho Park and Sung-Kweon Park. These collaborations have enhanced the quality and scope of his work, fostering a creative environment for developing impactful technologies.

Conclusion

In summary, Ki-Hyun Kim stands out as an influential inventor in the biotechnology field, particularly in cancer treatment innovations. His extensive patent portfolio and collaborative efforts highlight his dedication to advancing medical technology and improving patient outcomes.

Profile summary based on public USPTO records.